Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The result is what’s known as a “recombinant protein vaccine.” It’s made without live or dead versions of H5N1, relying on bits of genetic material from the virus to trigger the mouse’s ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The newest, updated Covid-19 vaccines are now FDA-approved and available, including the mRNA ones from Pfizer-BioNTech and Moderna and the recombinant one from Novavax.

The result is what’s known as a “recombinant protein vaccine.” It’s made without live or dead versions of H5N1, relying on bits of genetic material from the virus to trigger the mouse’s ...

Loopworm, a Bengaluru-based biomanufacturing company developing insect-derived proteins, has raised $3.25 million Pre-Series ...

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...